Đang chuẩn bị liên kết để tải về tài liệu:
Predictive biomarkers for the efficacy of nivolumab as≥ 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The phase 3 ATTRACTION-2 study demonstrated that nivolumab monotherapy improved survival compared to placebo in patients with pretreated advanced gastric cancer (AGC). However, the efficacy of nivolumab seems to be limited to a subset of patients. |

TÀI LIỆU LIÊN QUAN

Predictive biomarkers for the efficacy of nivolumab as≥ 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial

Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

Pre-operative biomarkers and imaging tests as predictors of post-operative delirium in non-cardiac surgical patients: A systematic review

Immune landscape of human prostate cancer: Immune evasion mechanisms and biomarkers for personalized immunotherapy

Immunotherapy for non-small cell lung cancers: Biomarkers for predicting responses and strategies to overcome resistance

Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary

Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Traffic lights for retinoids in oncology: Molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.